Simplify Logo

Full-Time

Experimental Crisprx Platform Developer

Posted on 6/28/2024

Vevo Therapeutics

Vevo Therapeutics

11-50 employees

AI-driven in vivo drug discovery platform

AI & Machine Learning
Biotechnology

Compensation Overview

$120k - $145kAnnually

Expert

San Bruno, CA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • In-depth experience in running CRISPRx screens for target deconvolution
  • Experience in scaling screening operations and training others
  • Experience in method development in the CRISPRx space
  • Experience and familiarity with programming for CRISPR screen analysis
  • Experience in building out oncology stories
  • Ph.D in relevant discipline required
Responsibilities
  • Lead and execute CRISPR screens at high-throughput
  • Scale and develop robust experimental/computational pipelines for conducting drug MOA deconvolution screens
  • Validate targets discovered from screens using traditional oncology assays
  • Develop new methods in the CRISPRx screening space

At Vevo Therapeutics, the development of the Mosaic platform represents a significant stride in the biotechnology sector by enabling a deeper understanding of drug-cell interactions in diverse patient populations with unparalleled single-cell precision. This company is a compelling place to work due to its focus on harnessing in vivo data and AI to revolutionize drug discovery, ensuring more personalized and effective treatments. The culture at Vevo Therapeutics likely fosters a collaborative and cutting-edge environment, essential for professionals eager to contribute to meaningful advancements in medicine.

Company Stage

Seed

Total Funding

$12M

Headquarters

San Francisco, California

Founded

2022

Growth & Insights
Headcount

6 month growth

-12%

1 year growth

15%

2 year growth

100%